Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Orchestra BioMed Holdings (OBIO) Debt to Equity: 2022-2025

Historic Debt to Equity for Orchestra BioMed Holdings (OBIO) over the last 2 years, with Sep 2025 value amounting to $0.32.

  • Orchestra BioMed Holdings' Debt to Equity was N/A to $0.32 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.32, marking a year-over-year change of. This contributed to the annual value of $0.43 for FY2024, which is N/A change from last year.
  • Latest data reveals that Orchestra BioMed Holdings reported Debt to Equity of $0.32 as of Q3 2025, which was down 99.33% from $48.76 recorded in Q2 2025.
  • In the past 5 years, Orchestra BioMed Holdings' Debt to Equity registered a high of $48.76 during Q2 2025, and its lowest value of $0.10 during Q1 2023.
  • Its 3-year average for Debt to Equity is $7.24, with a median of $0.32 in 2025.